Changes in brain tryptophan metabolism elicited by ageing, social environment, and psychological stress in mice

References

• Bonaccorso S, Marino V, Puzella A, Pasquini M, Biondi M, Artini M, Almerighi C, Verkerk R, Meltzer H, Maes M. Increased depressive ratings in patients with hepatitis C receiving interferon-alpha-based immunotherapy are related to interferon-alpha-induced changes in the serotonergic system. J Clin Psychopharmacol 2002; 22: 86–90
   PubMed Web of Science ®Google Scholar
• Capuron L, Ravaud A, Neveu PJ, Miller AH, Maes M, Dantzer R. Association between decreased serum tryptophan concentrations and depressive symptoms in cancer patients undergoing cytokine therapy. Mol Psychiatry 2002; 7: 468–473
   PubMed Web of Science ®Google Scholar
• Capuron L, Neurauter G, Musselman DL, Lawson DH, Nemeroff CB, Fuchs D, Miller AH. Interferon-alpha-induced changes in tryptophan metabolism relationship to depression and paroxetine treatment. Biol Psychiatry 2003; 54: 906–914
   PubMed Web of Science ®Google Scholar
• Curzon G, Friedel J, Knott PJ. The effect of fatty acids on the binding of tryptophan to plasma protein. Nature 1973; 242: 198–200
   PubMed Web of Science ®Google Scholar
• Delion S, Chalon S, Guilloteau D, Lejeune B, Besnard JC, Durand G. Age-related changes in phospholipid fatty acid composition and monoaminergic neurotransmission in the hippocampus of rats fed a balanced or an n-3 polyunsaturated fatty acid-deficient diet. J Lipid Res 1997; 38: 680–689
   PubMed Web of Science ®Google Scholar
• Gozlan H, Daval G, Verge D, Spampinato U, Fattaccini CM, Gallissot MC, el Mestikawy S, Hamon M. Aging associated changes in serotoninergic and dopaminergic pre- and postsynaptic neurochemical markers in the rat brain. Neurobiol Aging 1990; 11: 437–449
   Google Scholar
• Gramsbergen JB, Schmidt W, Turski WA, Schwarcz R. Age-related changes in kynurenic acid production in rat brain. Brain Res 1992; 588: 1–5
   PubMed Web of Science ®Google Scholar
• Guillemin GJ, Smythe G, Takikawa O, Brew BJ. Expression of indoleamine 2,3-dioxygenase and production of quinolinic acid by human microglia, astrocytes, and neurons. Glia 2004; 49: 15–23
   Web of Science ®Google Scholar
• Kendler KS, Kessler RC, Neale MC, Heath AC, Eaves LJ. The prediction of major depression in women: Toward an integrated etiologic model. Am J Psychiatry 1993; 150: 1139–1148
   PubMed Web of Science ®Google Scholar
• Konsman JP, Parnet P, Dantzer R. Cytokine-induced sickness behaviour: Mechanisms and implications. Trends Neurosci 2002; 25: 154–159
   PubMed Web of Science ®Google Scholar
• Laich A, Neurauter G, Widner B, Fuchs D. More rapid method for simultaneous measurement at tryptophan and kynurenine by HPLC. 2002; 48: 579–581, Clin.Chem
   Google Scholar
• Lee JM, Ross ER, Gower A, Paris JM, Martensson R, Lorens SA. Spatial learning deficits in the aged rat: Neuroanatomical and neurochemical correlates. Brain Res Bull 1994; 33: 489–500
   Google Scholar
• Luine V, Bowling D, Hearns M. Spatial memory deficits in aged rats: Contributions of monoaminergic systems. Brain Res 1990; 537: 271–278
   PubMed Web of Science ®Google Scholar
• McEwen BS. Protection and damage from acute and chronic stress: Allostasis and allostatic overload and relevance to the pathophysiology of psychiatric disorders. Ann NY Acad Sci 2004; 1032: 1–7
   PubMed Web of Science ®Google Scholar
• Miura H, Qiao H, Ohta T. Attenuating effects of the isolated rearing condition on increased brain serotonin and dopamine turnover elicited by novelty stress. Brain Res 2002a; 926: 10–17
   PubMed Web of Science ®Google Scholar
• Miura H, Qiao H, Ohta T. Influence of aging and social isolation on changes in brain monoamine turnover and biosynthesis of rats elicited by novelty stress. Synapse 2002b; 46: 116–124
   PubMed Web of Science ®Google Scholar
• Miura H, Qiao H, Kitagami T, Ohta T. Fluvoxamine, a selective serotonin reuptake inhibitor, suppresses tetrahydrobiopterin in the mouse hippocampus. Neuropharmacology 2004; 46: 340–348
   PubMed Web of Science ®Google Scholar
• Miura H, Qiao H, Kitagami T, Ohta T, Ozaki N. Effects of fluvoxamine on levels of dopamine, serotonin, and their metabolites in the hippocampus elicited by isolation housing and novelty stress in adult rats. Int J Neurosci 2005a; 115: 367–378
   PubMed Web of Science ®Google Scholar
• Miura H, Qiao H, Kitagami T, Ohta T, Ozaki N. Fluvoxamine, a selective serotonin reuptake inhibitor, suppresses tetrahydrobiopterin levels and dopamine as well as serotonin turnover in the mesoprefrontal system of mice. Psychopharmacology (Berl) 2005b; 177: 307–314
   PubMed Web of Science ®Google Scholar
• Miura H, Kitagami T, Ozaki N. Suppressive effect of paroxetine, a selective serotonin uptake inhibitor, on tetrahydrobiopterin levels and dopamine as well as serotonin turnover in the mesoprefrontal system of mice. Synapse 2007; 61: 698–706
   PubMed Web of Science ®Google Scholar
• Moffett JR, Namboodiri MA. Tryptophan and the immune response. Immunol Cell Biol 2003; 81: 247–265
   PubMed Web of Science ®Google Scholar
• Myint AM, Kim YK. Cytokine–serotonin interaction through IDO: A neurodegeneration hypothesis of depression. Med Hypotheses 2003; 61: 519–525
   PubMed Web of Science ®Google Scholar
• Myint AM, Kim YK, Verkerk R, Scharpe S, Steinbusch H, Leonard B. Kynurenine pathway in major depression: Evidence of impaired neuroprotection. J Affect Disord 2007; 98: 143–151
   PubMed Web of Science ®Google Scholar
• Pawlak D, Takada Y, Urano T, Takada A. Serotonergic and kynurenic pathways in rats exposed to foot shock. Brain Res Bull 2000; 52: 197–205
   PubMed Web of Science ®Google Scholar
• Paykel ES. Life events, social support and depression. Acta Psychiatr Scand Suppl 1994; 377: 50–58
   PubMedGoogle Scholar
• Ponzio F, Calderini G, Lomuscio G, Vantini G, Toffano G, Algeri S. Changes in monoamines and their metabolite levels in some brain regions of aged rats. Neurobiol Aging 1982; 3: 23–29
   PubMedGoogle Scholar
• Roy EJ, Takikawa O, Kranz DM, Brown AR, Thomas DL. Neuronal localization of indoleamine 2,3-dioxygenase in mice. Neurosci Lett 2005; 387: 95–99
   PubMed Web of Science ®Google Scholar
• Santiago M, Machado A, Reinoso-Suarez F, Cano J. Changes in biogenic amines in rat hippocampus during development and aging. Life Sci 1988; 42: 2503–2508
   Google Scholar
• Smith RS. The macrophage theory of depression. Med Hypotheses 1991; 35: 298–306
   PubMed Web of Science ®Google Scholar
• Stone TW, Darlington LG. Endogenous kynurenines as targets for drug discovery and development. Nat Rev Drug Discov 2002; 1: 609–620
   PubMed Web of Science ®Google Scholar
• Struder HK, Hollmann W, Platen P, Wostmann R, Weicker H, Molderings GJ. Effect of acute and chronic exercise on plasma amino acids and prolactin concentrations and on [3H]ketanserin binding to serotonin2A receptors on human platelets. Eur J Appl Physiol Occup Physiol 1999; 79: 318–324
   PubMed Web of Science ®Google Scholar
• Wichers MC, Maes M. The role of indoleamine 2,3-dioxygenase (IDO) in the pathophysiology of interferon-alpha-induced depression. J Psychiatry Neurosci 2004; 29: 11–17
   PubMed Web of Science ®Google Scholar
• Wichers MC, Koek GH, Robaeys G, Verkerk R, Scharpe S, Maes M. IDO and interferon-alpha-induced depressive symptoms: A shift in hypothesis from tryptophan depletion to neurotoxicity. Mol Psychiatry 2005; 10: 538–544
   PubMed Web of Science ®Google Scholar
• Widner B, Werner ER, Schennach H, Wachter H, Fuchs D. Simultaneous measurement of serum tryptophan and kynurenine by HPLC. Clin Chem 1997; 43: 2424–2426
   PubMed Web of Science ®Google Scholar
• Widner B, Leblhuber F, Walli J, Tilz GP, Demel U, Fuchs D. Tryptophan degradation and immune activation in Alzheimer's disease. J Neural Transm 2000; 107: 343–353
   PubMed Web of Science ®Google Scholar
• Widner B, Laich A, Sperner-Unterweger B, Ledochowski M, Fuchs D. Neopterin production, tryptophan degradation, and mental depression—what is the link?. Brain Behav Immun 2002; 16: 590–595
   PubMed Web of Science ®Google Scholar